Hypoxic Culture Conditions for Mesenchymal Stromal/Stem Cells from Wharton’s Jelly: A Critical Parameter to Consider in a Therapeutic Context

Publisher： Bentham Science Publishers

E-ISSN： 2212-3946|9|4|306-318

ISSN： 1574-888X

Source： Current Stem Cell Research & Therapy, Vol.9, Iss.4, 2014-07, pp. : 306-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of Unengineered and Engineered Wharton’s Jelly Mesenchymal Stem Cells as Cancer Inhibitor Agent

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 15, Iss. 2, 2015-08 ,pp. : 128-10

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Wharton’s Jelly Derived Fetal Mesenchymal Cells with Tumor Cells

By  

Current Stem Cell Research & Therapy, Vol. 9, Iss. 6, 2014-11 ,pp. : 504-507

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells Derived from Wharton's Jelly of the Umbilical Cord: Biological Properties and Emerging Clinical Applications

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 2, 2013-03 ,pp. : 144-155

Bentham Science Publishers

Access to resources Recommend Favorite

New Frontiers in Regenerative Medicine in Cardiology: The Potential of Wharton's Jelly Mesenchymal Stem Cells

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 1, 2013-01 ,pp. : 39-45

Bentham Science Publishers

Access to resources Recommend Favorite

Wharton's Jelly or Bone Marrow Mesenchymal Stromal Cells Improve Cardiac Function Following Myocardial Infarction for More Than 32 Weeks in a Rat Model: A Preliminary Report

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 1, 2013-01 ,pp. : 46-59

Bentham Science Publishers

Access to resources Recommend Favorite